Prof. Laura Parkkinen is a translational neuropathologist with 20 years of experience in neuropathological research and diagnosis of neurodegenerative diseases, particularly in Parkinson’s disease (PD), Alzheimer’s disease (AD) and related synucleinopathies, such as dementia with Lewy bodies (DLB). She is a director of the Oxford brain bank and oversees a collection of one of the pathologically best-characterized dementia/PD and healthy control cohorts in the word. She also has well-established connections to other European the brain banks that collect PD/DLB/AD brains. She has established an internationally recognized multidisciplinary research group that is generating novel biomarkers and treatment avenues for PD, DLB and AD by integrating next-generation neuropathology (including digital pathology and deep-learning algorithms) with proteomics, spatial transcriptomics, genomics and clinical measures.